-transparent.png){kind=logo}
3-tert-Butyl-4-hydroxyanisole is oxidatively metabolized in the presence of rat liver microsomes, reduced nicotinamide adenine dinucleotide phosphate, and oxygen to yield tert-butylhydroquinone, tert-butylquinone, and a polar metabolite(s). In the presence of human and rat liver microsomes or eight purified cytochrome P-450 isozymes reconstituted with NADPH-cytochrome P-450 reductase, this phenolic antioxidant is converted to the oxidoreduction-active metabolite, tert-butylquinone, that can stimulate the NADPH oxidase activities of these preparations by 2- to 7-fold. The rate of formation of each of the metabolites of 3-tert-butyl-4-hydroxyanisole was increased by pretreatment of rats with either 5,6-benzoflavone or phenobarbital. In addition the tert-butylhydroquinone and tert-butylquinone concentrations in solution reached apparent steady-state levels during metabolism; the steady-state concentrations were also increased by various animal pretreatment regimens. Furthermore it was shown that the metabolism of 3-tert-butyl-4-hydroxyanisole yielded material which was covalently bound to protein. In the presence of glutathione the rates of formation of the polar metabolite(s) were enhanced 3- to 4-fold, while covalently bound products were nearly stoichiometrically decreased. The increase in the amount of polar metabolite was due to the formation of a 3-tert-butyl-4-hydroxyanisole-glutathione conjugate. 3-tert-Butyl-4-hydroxyanisole was also oxidatively metabolized by rat lung microsomes to yield the polar metabolite(s) and tert-butylhydroquinone. The polar metabolite(s), tert-butylquinone, and tert-butylhydroquinone were also shown to be formed in isolated hepatocyte suspensions. They could be found as either the free hydroquinone, the sulfate conjugate, the glucuronide conjugate, and polar metabolites, presumedly the 3-tert-butyl-4-hydroxyanisole-glutathione conjugate. The total tert-butylhydroquinone concentration attained a steady-state level in a manner similar to that seen with the microsomal suspensions. In addition 3-tert-butyl-4-hydroxyanisole itself formed sulfate and glucuronide conjugates, the glucuronide being the major product.
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
October 1989,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
April 1985,
Cancer research,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
August 1994,
European journal of pharmacology,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
January 1992,
Drug metabolism and disposition: the biological fate of chemicals,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
November 1984,
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
January 1991,
Chemical research in toxicology,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
October 2002,
Drug metabolism and disposition: the biological fate of chemicals,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
July 1982,
Chemico-biological interactions,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
December 1988,
Toxicology,
S W Cummings, and
G A Ansari, and
F P Guengerich, and
L S Crouch, and
R A Prough
January 2003,
Chemico-biological interactions,
